VF
ALLR

Virtu Financial’s Allarity Therapeutics ALLR Stock Holding History

Virtu Financial’s Portfolio ALLR Stock Details ALLR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20K Buy
+15,322
New +$21.7K ﹤0.01% 1345
2024
Q3 		– Sell
-8,845
Closed -$56K – 1327
2024
Q2 		$56K Buy
+8,845
New +$347K ﹤0.01% 890
2024
Q1 		– Sell
-25
Closed -$8K – 1368
2023
Q4 		$8K Sell
25
-18
-42% -$6.24K ﹤0.01% 1428
2023
Q3 		$19K Buy
+43
New +$55.1K ﹤0.01% 1019

Other funds holding ALLR

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MCM
Militia Capital Management Austin, Texas $3.37B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Virtu Financial's ALLR Position: Q2 2026 in Review

Virtu Financial opened a new position in Allarity Therapeutics (ALLR) in Q2 2026: 15,322 shares worth $20K. The stake represents ﹤0.01% of the portfolio and ranks #1345 among its holdings. This is a return to the name: Virtu Financial previously reported a position in ALLR as recently as Q2 2024.

Virtu Financial first reported a position in ALLR in Q3 2023 and has held it in 4 quarters since. The position peaked at $56K in Q2 2024. 19 funds tracked by Wall St. Rank hold ALLR as of Q2 2026.

  • Virtu Financial held 15,322 shares of Allarity Therapeutics worth $20K as of Q2 2026.
  • Allarity Therapeutics was a new Virtu Financial position in Q2 2026.
  • Allarity Therapeutics made up ﹤0.01% of Virtu Financial's portfolio in Q2 2026, its #1345 holding.
  • Virtu Financial first reported a position in Allarity Therapeutics in Q3 2023 and has held it in 4 quarters since.
  • Virtu Financial's Allarity Therapeutics position peaked at $56K in Q2 2024.
  • 19 funds tracked by Wall St. Rank held Allarity Therapeutics as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.